XT
VBIO

XTX Topco’s Valion Bio VBIO Stock Holding History

XTX Topco’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-420
Closed -$9.31K – 4702
2026
Q1 		$9.31K Buy
+420
New +$10.7K ﹤0.01% 3700

Other funds holding VBIO

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco's VBIO Position: Q2 2026 in Review

XTX Topco sold out of Valion Bio (VBIO) in Q2 2026, closing a stake of 420 shares — an estimated $9.31K sold.

XTX Topco first reported a position in VBIO in Q1 2026 and held it in 1 quarter. The position peaked at $9.31K in Q1 2026. 11 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.

  • XTX Topco reported no remaining Valion Bio position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 420 Valion Bio shares in Q2 2026, an estimated $9.31K.
  • XTX Topco first reported a position in Valion Bio in Q1 2026 and held it in 1 quarter.
  • XTX Topco's Valion Bio position peaked at $9.31K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.